Latest news
Neurocrine advances GLP-1/GIP/glucagon triple agonist into first-in-human obesity study - AllSciAllSci · Fri, 07 Aug 2026 16:26:00 GMTFDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - AllSciAllSci · Tue, 04 Aug 2026 12:20:33 GMTShape Therapeutics secures funding to advance one-time gene therapy for Parkinson's disease. - AllSciAllSci · Wed, 29 Jul 2026 07:00:00 GMT